Common Contracts
3 similar Replacement Stock Option Agreement contracts by Celgene Corp /De/, Korn Ferry International, Sangamo Biosciences Inc
EXHIBIT (d)(3) KORN/FERRY INTERNATIONAL PERFORMANCE AWARD PLAN REPLACEMENT STOCK OPTION AGREEMENT THIS REPLACEMENT STOCK OPTION AGREEMENT (the "Option Agreement") by and between Korn/Ferry International, a Delaware Corporation (the "Company"), and...Replacement Stock Option Agreement • February 25th, 2002 • Korn Ferry International • Services-employment agencies • California
EFFECTIVE DATE: JULY 4, 2001 SANGAMO BIOSCIENCES, INC. REPLACEMENT STOCK OPTION AGREEMENT Dear (Name): As you know, on July 4, 2001 (the "Closing Date") Sangamo BioSciences, Inc. ("Sangamo") acquired Gendaq Limited ("Gendaq") (the "Acquisition"). In...Replacement Stock Option Agreement • July 5th, 2001 • Sangamo Biosciences Inc • Biological products, (no disgnostic substances)
As you know, on July 4, 2001 (the "Closing Date") Sangamo BioSciences, Inc. ("Sangamo") acquired Gendaq Limited ("Gendaq") (the "Acquisition"). In the Acquisition, each share of Gendaq common stock was exchanged for 1.13969 of a share of Sangamo common stock (the "Exchange Ratio"). On the Closing Date you held one or more outstanding options to purchase shares of Gendaq Limited common stock granted to you under the Gendaq Limited 2001 Enterprise Management Incentive Share Option Plan (the "Plan") and documented with a Stock Option Agreement(s) (the "Option Agreement") issued to you under the Plan (the "Gendaq Options"). In accordance with the Acquisition, on the Closing Date Sangamo has agreed to grant you a new option in replacement of your prior Gendaq stock option (the "Replacement Option").
CELGENE CORPORATION OPTION AGREEMENT PURSUANT TO THE REPLACEMENT STOCK OPTION PLANReplacement Stock Option Agreement • May 19th, 1998 • Celgene Corp /De/ • Pharmaceutical preparations
